Fredrick B Hagemeister Selected Research

Prednisone (Sone)

3/2015	Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
12/2013	Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.
2/2003	Rituximab and chemotherapy for aggressive lymphomas: a significant advance in therapy.
1/2003	NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fredrick B Hagemeister Research Topics

Disease

25	Lymphoma (Lymphomas) 11/2023 - 05/2002
15	Neoplasms (Cancer) 12/2023 - 03/2002
12	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2015 - 06/2003
11	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 12/2002
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2022 - 12/2013
8	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 04/2006
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2022 - 07/2010
4	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 02/2003
4	Disease Progression 06/2014 - 05/2002
3	Neutropenia 01/2018 - 07/2005
2	Opportunistic Infections (Opportunistic Infection) 10/2021 - 07/2005
2	Cytopenia 10/2021 - 05/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 11/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 06/2005
2	Thrombocytopenia (Thrombopenia) 01/2018 - 11/2015
1	Exanthema (Rash) 11/2023
1	Long Term Adverse Effects 10/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	cell-associated neurotoxicity 01/2020
1	Serositis 01/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2019
1	Plasmablastic Lymphoma 03/2016
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2015
1	Radiation Pneumonitis 05/2015
1	Cardiotoxicity 03/2015
1	Metabolic Bone Diseases (Osteopenia) 04/2013
1	Venous Thromboembolism 10/2010

Drug/Important Bio-Agent (IBA)

18	Rituximab (Mabthera)FDA Link 11/2023 - 02/2003
8	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2003
6	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 07/2010
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2003
6	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 01/2003
6	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2021 - 12/2002
6	fludarabineIBA 01/2021 - 12/2002
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 07/2010
4	ibrutinibIBA 11/2023 - 01/2019
4	Lenalidomide (CC 5013)FDA Link 11/2023 - 11/2014
4	Prednisone (Sone)FDA LinkGeneric 03/2015 - 01/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2013
3	InterferonsIBA 01/2017 - 07/2005
3	Topotecan (Hycamtin)FDA LinkGeneric 10/2014 - 05/2002
2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 06/2005
2	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2022
2	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2020
2	axicabtagene ciloleucelIBA 10/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 07/2005
2	IceIBA 01/2018 - 05/2002
2	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 05/2002
2	Ifosfamide FDA LinkGeneric 01/2018 - 05/2002
2	liposomal doxorubicin (Doxil)FDA Link 11/2015 - 03/2015
2	N 30IBA 11/2014 - 03/2002
2	Alkylating AgentsIBA 04/2013 - 02/2004
2	Vinblastine (Vinblastine Sulfate)FDA Link 05/2012 - 01/2003
2	denileukin diftitox (Ontak)FDA Link 02/2007 - 10/2004
2	Proteins (Proteins, Gene)FDA Link 02/2007 - 10/2004
1	Immunoglobulins (Immunoglobulin)IBA 12/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Vorinostat FDA Link 11/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2020
1	Sirolimus (Rapamycin)FDA Link 11/2020
1	Everolimus FDA Link 11/2020
1	Histone Deacetylase InhibitorsIBA 11/2020
1	MTOR InhibitorsIBA 11/2020
1	romidepsin (FK228)FDA Link 01/2020
1	MLN 8237IBA 01/2020
1	PanobinostatIBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2017
1	R-CHOP protocolIBA 03/2015
1	1-dodecylpyridoxal (PLD)IBA 03/2015
1	AnthracyclinesIBA 03/2015
1	Dihydrotachysterol (AT 10)IBA 11/2014
1	PlatinumIBA 10/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2013
1	Zoledronic Acid (Zometa)FDA Link 04/2013
1	Vitamin D FDA LinkGeneric 04/2013
1	CalciumIBA 04/2013
1	Dacarbazine (DIC)FDA LinkGeneric 05/2012
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2012
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2012
1	Hemoglobins (Hemoglobin)IBA 10/2010

Therapy/Procedure

28	Therapeutics 11/2021 - 05/2002
21	Drug Therapy (Chemotherapy) 01/2022 - 03/2002
10	Radiotherapy 12/2017 - 03/2002
2	Stem Cell Transplantation 07/2010 - 12/2002
2	Aftercare (After-Treatment) 07/2010 - 01/2003
2	Combined Modality Therapy 02/2004 - 06/2003
1	Radioimmunotherapy 01/2021
1	Transplantation 01/2021
1	Hematopoietic Stem Cell Transplantation 05/2015
1	Animal Assisted Therapy 06/2014
1	Drug Tapering 05/2012